Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 13, 2026
The ClearBridge Mid Cap Growth Strategy mildly underperformed its Russell Midcap Growth Index benchmark during the third quarter of 2026, as positive stock selection within information technology, health care, and industrials was offset by an overweight allocation to industrials alongside selection headwinds in energy. While the benchmark retreated 5.8% during the period, absolute contributions across the strategy remained confined to three of eleven invested sectors, led by information technology and health care holdings. Portfolio managers maintained disciplined sector positioning while navigating shifting factor dynamics and broader macro volatility across mid-cap growth equities. The investment team characterizes the current macroeconomic regime as decidedly 'K-shaped,' complicated by rising financing costs, the 10-year Treasury yield eclipsing 5%, and elevated crude oil prices exceeding $100 per barrel driven by Middle East geopolitical unrest. In response to these stagflationary crosscurrents, higher mortgage rates above 7.25%, and pinched consumer discretionary income, the strategy prioritizes two core secular narratives: capital reallocation toward emerging beneficiaries of enterprise artificial intelligence adoption, and high-conviction exposure to resilient industrial compounders possessing durable pricing power. Portfolio turnover during the quarter reflected active repositioning toward durable economic value. The managers initiated new growth positions in Snowflake, Teradyne, Keysight Technologies, DigitalOcean, Vulcan Materials, and Affirm, while scaling up existing stakes in Robinhood Markets and Astera Labs. Capital was redeployed by completely exiting positions in Martin Marietta Materials, STERIS, Bio-Techne (following its acquisition by Merck KGaA), Ferguson Enterprises, Tradeweb Markets, DraftKings, and Roblox to eliminate capital allocation risks and reduce cyclical non-residential industrial exposure.
ClearBridge Mid Cap Growth Strategy seeks to compound capital across market cycles by investing in misunderstood or underappreciated growth companies characterized by disciplined capital management, robust balance sheets, and structural exposure to secular growth themes such as enterprise AI adoption.
ClearBridge anticipates that while AI data center infrastructure buildouts remain foundational, market leadership will increasingly rotate toward enterprises that effectively leverage AI to accelerate top-line growth, enhance workforce productivity, and transform operating models. Amid a persistent K-shaped economy, higher borrowing costs, elevated fuel expenses, and upcoming midterm election volatility, the strategy remains centered on stock-specific selection of underappreciated compounders boasting robust balance sheets and disciplined capital allocation.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with ClearBridge Mid Cap Growth Strategy or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.